Skip to main content

Advertisement

Articles

Page 51 of 51

  1. Mantle Cell Lymphoma (MCL) is a well-known histological and clinical subtype of B-cell non-Hodgkin's Lymphomas. It is usually characterized by an aggressive disease course, presenting with advanced stage disea...

    Authors: Andrea Riccardo Filippi, Pierfrancesco Franco, Marco Galliano and Umberto Ricardi

    Citation: Radiation Oncology 2006 1:35

    Content type: Short report

    Published on:

  2. The dose distribution to the rectum, delineated as solid organ, rectal wall and rectal surface, in 3D conformal (3D-CRT) and intensity-modulated radiotherapy treatment (IMRT) planning for localized prostate ca...

    Authors: Matthias Guckenberger, Jürgen Meyer, Kurt Baier, Dirk Vordermark and Michael Flentje

    Citation: Radiation Oncology 2006 1:34

    Content type: Research

    Published on:

  3. As a foundation for a dose escalation trial, we sought to characterize duodenal and non-duodenal small bowel organ motion between fractions of pancreatic radiation therapy.

    Authors: Anurag K Singh, Ryan M Tierney, Daniel A Low, Parag J Parikh, Robert J Myerson, Joseph O Deasy, Catherine S Wu, Gisele C Pereira, Sasha H Wahab, Sasa MS Mutics, Perry W Grigsby and Andrew J Hope

    Citation: Radiation Oncology 2006 1:33

    Content type: Research

    Published on:

  4. Modern radiotherapy (RT) reduces the side effects at organ at risk. However, skin toxicity is still a major problem in many entities, especially head and neck cancer. Some substances like chemotherapy provide ...

    Authors: Kurt Putnik, Peter Stadler, Christof Schäfer and Oliver Koelbl

    Citation: Radiation Oncology 2006 1:32

    Content type: Short report

    Published on:

  5. Intensity modulated radiotherapy (IMRT) is a powerful tool, which might go a long way in reducing radiation doses to critical structures and thereby reduce long term morbidities.

    Authors: Tejinder Kataria, Sheh Rawat, SN Sinha, C Garg, NK Bhalla and PS Negi

    Citation: Radiation Oncology 2006 1:31

    Content type: Methodology

    Published on:

  6. We prospectively reviewed response rates, local control, and side effects after non-fractionated stereotactic high single-dose body radiation therapy for lung tumors.

    Authors: Peter Fritz, Hans-Jörg Kraus, Werner Mühlnickel, Udo Hammer, Wolfram Dölken, Walburga Engel-Riedel, Assad Chemaissani and Erich Stoelben

    Citation: Radiation Oncology 2006 1:30

    Content type: Research

    Published on:

  7. To investigate the outcome of HIV-seropositive patients under highly active antiretroviral treatment (HAART) with anal cancer treated with radiotherapy (RT) alone or in combination with standard chemotherapy (...

    Authors: Christoph Oehler-Jänne, Burkhardt Seifert, Urs M Lütolf and I Frank Ciernik

    Citation: Radiation Oncology 2006 1:29

    Content type: Research

    Published on:

  8. To report early observation of transient PSA elevations on this pilot study of external beam radiation therapy and magnetic resonance imaging (MRI) guided high dose rate (HDR) brachytherapy boost.

    Authors: Anurag K Singh, Peter Guion, Robert C Susil, Deborah E Citrin, Holly Ning, Robert W Miller, Karen Ullman, Sharon Smith, Nancy Sears Crouse, Denise J Godette, Bronwyn R Stall, CNorman Coleman, Kevin Camphausen and Cynthia Ménard

    Citation: Radiation Oncology 2006 1:28

    Content type: Research

    Published on:

  9. Salvage therapy in head and neck cancer (HNC) is a controversy issue and the literature is scarce regarding the use of interstitial high-dose rate brachytherapy (I-HDR) in HNC. We evaluated the long-term resul...

    Authors: Antonio CassioAssis Pellizzon, João Victor Salvajoli, Luiz Paulo Kowalski and Andre Lopes Carvalho

    Citation: Radiation Oncology 2006 1:27

    Content type: Research

    Published on:

  10. Helical Tomotherapy (HT) integrates linear accelerator and computerized tomography (CT) technology to deliver IMRT. Targets are localized (i.e. outlined as gross tumor volume [GTV] and planning target volume [...

    Authors: José A Peñagarícano, Yulong Yan, Chengyu Shi, Mark E Linskey and Vaneerat Ratanatharathorn

    Citation: Radiation Oncology 2006 1:26

    Content type: Research

    Published on:

  11. The tumor response to preoperative radiotherapy of locally advanced rectal cancer varies greatly, warranting the use of experimental models to assay the efficacy of molecular targeting agents in rectal cancer ...

    Authors: Kjersti Flatmark, Ragnhild V Nome, Sigurd Folkvord, Åse Bratland, Heidi Rasmussen, Mali Strand Ellefsen, Øystein Fodstad and Anne Hansen Ree

    Citation: Radiation Oncology 2006 1:25

    Content type: Research

    Published on:

  12. To report the relapse and survival rates associated to treatment for patients with stage IC, grade 2 or grade 3 and IB grade 3 diseases considered high risk patients group for relapse.

    Authors: Gustavo A Viani, Barbara F Patia, Antonio C Pellizzon, Marcel D De Melo, Paulo E Novaes, Ricardo C Fogaroli, Maria A Conte and Joao V Salvajoli

    Citation: Radiation Oncology 2006 1:24

    Content type: Research

    Published on:

  13. The aim of the study was to evaluate the clinical outcome of intensity modulated radiotherapy (IMRT) in 46 patients with paranasal sinus tumors with special respect to treatment-related toxicity.

    Authors: Stephanie E Combs, Stephan Konkel, Daniela Schulz-Ertner, Marc W Münter, Jürgen Debus, Peter E Huber and Christoph Thilmann

    Citation: Radiation Oncology 2006 1:23

    Content type: Research

    Published on:

  14. There is no consensus as to the prognostic model for brachytherapy of tongue carcinoma. This study was designed to evaluate the prognostic factors for local control based on a large population under a unified ...

    Authors: Sayako Oota, Hitoshi Shibuya, Ryo-ichi Yoshimura, Hiroshi Watanabe and Masahiko Miura

    Citation: Radiation Oncology 2006 1:21

    Content type: Research

    Published on:

  15. To evaluate the prognostic factors associated with overall survival in patients with brain metastasis treated with whole brain radiotherapy (WBRT) and estimate the potential improvement in survival for patient...

    Authors: Elisa Y Saito, Gustavo A Viani, Robson Ferrigno, Ricardo A Nakamura, Paulo E Novaes, Cassio A Pellizzon, Ricardo C Fogaroli, Maria A Conte and Joao V Salvajoli

    Citation: Radiation Oncology 2006 1:20

    Content type: Research

    Published on:

  16. Patients with brain metastases represent a heterogeneous group where selection of the most appropriate treatment depends on many patient- and disease-related factors. Eventually, a considerable proportion of p...

    Authors: Carsten Nieder, Anca L Grosu, Sabrina Astner, Reinhard Thamm and Michael Molls

    Citation: Radiation Oncology 2006 1:19

    Content type: Review

    Published on:

  17. To investigate the potential of parotic gland sparing of intensity modulated radiotherapy (3D-c-IMRT) performed with metallic compensators for head and neck cancer in a clinical series by analysis of dose dist...

    Authors: Thomas G Wendt, Nasrin Abbasi-Senger, Henning Salz, Ines Pinquart, Sven Koscielny, Susi-Marie Przetak and Tilo Wiezorek

    Citation: Radiation Oncology 2006 1:18

    Content type: Research

    Published on:

  18. Presenting the initial clinical results in the treatment of complex shaped adenoid cystic carcinomas (ACC) of the head and neck region by inverse planned stereotactic IMRT.

    Authors: MW Münter, D Schulz-Ertner, H Hof, A Nikoghosyan, A Jensen, S Nill, P Huber and J Debus

    Citation: Radiation Oncology 2006 1:17

    Content type: Research

    Published on:

  19. The purpose of the study was the clinical implementation of a kV cone beam CT (CBCT) for setup correction in radiotherapy.

    Authors: Christoph Thilmann, Simeon Nill, Thomas Tücking, Angelika Höss, Bernd Hesse, Lars Dietrich, Rolf Bendl, Bernhard Rhein, Peter Häring, Christian Thieke, Uwe Oelfke, Juergen Debus and Peter Huber

    Citation: Radiation Oncology 2006 1:16

    Content type: Research

    Published on:

  20. Cervical cancer continues to be a significant health burden worldwide. Globally, the majority of cancers are locally advanced at diagnosis; hence, radiation remains the most frequently used therapeutical modal...

    Authors: Myrna Candelaria, Alicia Garcia-Arias, Lucely Cetina and Alfonso Dueñas-Gonzalez

    Citation: Radiation Oncology 2006 1:15

    Content type: Review

    Published on:

  21. The risk of severe cardiovascular toxicity, specifically thromboembolic events (TE), in patients with cervical cancer receiving concurrent irradiation and cisplatin chemotherapy is reported to be less than 1% ...

    Authors: Jon C Anders, Perry W Grigsby and Anurag K Singh

    Citation: Radiation Oncology 2006 1:14

    Content type: Review

    Published on:

  22. To evaluate intensity-modulated radiation therapy (IMRT) as an alternative to conformal radiotherapy (CRT) or 4-field box boost (4FB) in women with gynecologic malignancies who are unsuitable for brachytherapy...

    Authors: Philip Chan, Inhwan Yeo, Gregory Perkins, Anthony Fyles and Michael Milosevic

    Citation: Radiation Oncology 2006 1:13

    Content type: Research

    Published on:

  23. The presentation reviews the modus operandi of the dose modifying drug Pentoxifylline and the dose enhancement factors which can be achieved in different cell types. Preclinical and clinical data show that Pen...

    Authors: Lothar Bohm

    Citation: Radiation Oncology 2006 1:12

    Content type: Review

    Published on:

  24. Epidermal growth factor receptor (EGFR) is a member of the ErbB family of receptors. Its stimulation by endogenous ligands, EGF or transforming growth factor-alpha (TGF-α) results in activation of intracellula...

    Authors: Michel Zimmermann, Abderrahim Zouhair, David Azria and Mahmut Ozsahin

    Citation: Radiation Oncology 2006 1:11

    Content type: Review

    Published on:

  25. The long-term dose-effect relationship for specific cardiac structures in mediastinal radiotherapy has rarely been investigated. As part of an interdisciplinary project, the 3-D dose distribution within the he...

    Authors: Dirk Vordermark, Ines Seufert, Franz Schwab, Oliver Kölbl, Margret Kung, Christiane Angermann and Michael Flentje

    Citation: Radiation Oncology 2006 1:10

    Content type: Research

    Published on:

  26. Current approaches for the improvement of bNED for prostate cancer patients treated with radiotherapy mainly focus on dose escalation. However molecularly targeted approaches may also turn out to be of value. ...

    Authors: U Ganswindt, W Budach, V Jendrossek, G Becker, M Bamberg and C Belka

    Citation: Radiation Oncology 2006 1:9

    Content type: Research

    Published on:

  27. Respiration-gated radiotherapy can permit the irradiation of smaller target volumes. 4DCT scans performed for routine treatment were retrospectively analyzed to establish the benefits of gating in stage III no...

    Authors: René WM Underberg, John R van Sörnsen de Koste, Frank J Lagerwaard, Andrew Vincent, Ben J Slotman and Suresh Senan

    Citation: Radiation Oncology 2006 1:8

    Content type: Research

    Published on:

  28. Alkylphosphocholines constitute a novel class of antineoplastic synthetic phospholipid derivatives that induce apoptosis of human tumor cell lines by targeting cellular membranes. We could recently show that t...

    Authors: Amelie Rübel, René Handrick, Lars H Lindner, Matthias Steiger, Hansjörg Eibl, Wilfried Budach, Claus Belka and Verena Jendrossek

    Citation: Radiation Oncology 2006 1:6

    Content type: Research

    Published on:

  29. To report the retrospective analysis of patients with locally advanced rectal cancer treated with neodjuvant radiochemotherapy.

    Authors: Robson Ferrigno, Paulo Eduardo Ribeiro dos Santos Novaes, Maria Letícia Gobo Silva, Ines Nobuko Nishimoto, Wilson Toshihiko Nakagawa, Benedito Mauro Rossi, Fábio de Oliveira Ferreira and Ademar Lopes

    Citation: Radiation Oncology 2006 1:5

    Content type: Research

    Published on:

  30. This study investigated whether changing a tumor's oxygenation would alter tumor metabolism, and thus uptake of 18F-FDG (fluorine-18 deoxyglucose), a marker for glucose metabolism using positron emission tomograp...

    Authors: Linda W Chan, Sebastien Hapdey, Sean English, Jurgen Seidel, Joann Carson, Anastasia L Sowers, Murali C Krishna, Michael V Green, James B Mitchell and Stephen L Bacharach

    Citation: Radiation Oncology 2006 1:3

    Content type: Research

    Published on:

  31. We sought to determine the intra- and inter-radiation therapist reproducibility of a previously established matching technique for daily verification and correction of isocenter position relative to intraprost...

    Authors: Karen L Ullman, Holly Ning, Robert C Susil, Asna Ayele, Lucresse Jocelyn, Jan Havelos, Peter Guion, Huchen Xie, Guang Li, Barbara C Arora, Angela Cannon, Robert W Miller, C Norman Coleman, Kevin Camphausen and Cynthia Ménard

    Citation: Radiation Oncology 2006 1:2

    Content type: Research

    Published on:

  32. Radiotherapy continues to be a major treatment for solid tumours and is a cornerstone of modern oncology. The term 'radiation oncology' describes the integration of radiation therapy into the complexity of mul...

    Authors: Claus Belka and Kevin A Camphausen

    Citation: Radiation Oncology 2006 1:1

    Content type: Editorial

    Published on:

Annual Journal Metrics

Advertisement